Viveve Medical Inc.
Latest From Viveve Medical Inc.
Starts & Stops: CardioFocus Studies HeartLight X3 In Persistent AF; IntraLink Spine Launches Trial Of Low-Back Device In Australia
Starts & Stops compiles all the clinical trial announcements, initiations, completions and suspensions tracked by Meddevicetracker. This edition covers trial announcements from March 4 through March 17, including trial announcements from CardioFocus, Innovative Cardiovascular Solutions, IntraLink-Spine, Geneveve, Acutus, and Stereotaxis.
A snapshot of global medical device and diagnostics approvals recorded during the past week in Medtech Insight's Approvals Tracker. This week, two Health Canada approvals, and more.
Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, the bimonthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. In this edition, we highlight industry pacts that were sealed in July and August 2017.
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment – In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type – Acquisition, Alliance, or Financing. This month’s column covers deals announced in August 2017.
- Radiofrequency Devices
Surgical Equipment & Devices
- Minimally or Less Invasive
- Therapeutic Areas
- Gynecological, Urological
- PLC Systems Inc.
- North America
- Parent & Subsidiaries
- Viveve Medical Inc.
- Senior Management
Scott Durbin, CEO
Jim Robbins, VP, Fin. & Admin. & Principle Accounting Officer
James Atkinson, Pres. & CBO
Jim Maffezzoli, VP, Global Mktg.
Suzon Lommel , SVP, Reg. & Quality Affairs
Marty Kerber, VP, Operations
- Contact Info
Viveve Medical Inc.
Phone: (720) 696-8100
345 Inverness Dr. South, Bldg. B
Englewood, CO 80112
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.